Forgot password?
Sign up today and your first download is free.
REGISTER
The U.S. Trade Representative’s Special 301 report uses new, tougher language to call out a handful of countries for using or threatening to use compulsory licenses, which USTR says is undermining rights holders and forcing American patients to fund research and development for new drugs.
Senate Foreign Relations ranking member Ben Cardin (D-MD) is blasting the Trump administration's linkage of U.S. trade policy toward China with action on North Korea as dangerous and beneficial only for China.
The Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on Friday (Nov. 6) formally approved three waivers exempting least-developed countries (LDCs) from implementing TRIPS obligations on pharmaceuticals for 17 years, according to a World Trade Organization press release.